Bridging and Disease Status Before CD19 CAR T

Company EBMT; GoCART (academic consortium) Event Type Peer-reviewed publication (Bone Marrow Transplantation) Modality Autologous CD19 CAR T (axi-cel, tisa-cel) Asset Commercial CD19 CAR T Target CD19 Disease Area Relapsed or refractory large B-cell lymphoma Summary An EBMT and GoCART analysis of 1,134 adults receiving commercial…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *